Company intelligence / Profile preview

NemetzGroup

Boston, Massachusetts, United Statesnemetzgroup.com ↗

Ownership: Private
Employees: ~17
Development stage: Other

Overview

The NemetzGroup does not have its own clinical results but has supported over 250 biopharma companies in developing and launching assets from early-stage development through commercialization. They are recognized for their expertise in commercialization strategy and hands-on support across the product lifecycle.

Therapeutic areas: OncologyMetabolic DisordersImmunologyRare DiseasesHematologyGastroenterologyCardiovascularOphthalmologyNeurologyInfectious Diseases
Modalities: Small molecule therapyGene therapyCell therapyBiologic (including Antibody, Protein)Radiopharmaceuticals/ImagingContrast media
Industry: Consulting

Partnerships

No specific major pharmaceutical or biotech partnerships disclosed.Works with >250 biopharma clients as strategic advisor.

Beyond the preview

Go deeper on NemetzGroup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NemetzGroup.

Explore the full profile